Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression
Centre Hospitalier Universitaire de Nīmes
FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression
Brian Barnett
A Study of Dosing Patterns and Costs in Patients With Spinal Muscular Atrophy Receiving Disease Modifying Therapies
Novartis Pharmaceuticals
A Real-world Study Comparing the Effectiveness of Ofatumumab and Ocrelizumab Treatment in Multiple Sclerosis Patients
Novartis Pharmaceuticals
Effect of Ketamine, Amitriptyline and Their Combination on Itch
Aalborg University
Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy
Tatiana Aboulafia Brakha
Use of Ketamine in Severe Pain Syndromes
Erasme University Hospital
Low-Income Group Psilocybin Assisted Therapy for Depression
Matthew Hicks
Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
Yale University
Psilocybin for Treatment-Resistant Depression
University of Colorado, Denver
(GluEsk) Glutamate and Esketamine
University of Oxford
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
University Hospital, Basel, Switzerland
Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients
Cessatech A/S
Comparison of Total Intravenous Anesthesia and Inhalational Anesthesia in Opioid-Free Anesthesia for Bariatric Surgery: A Randomized Controlled Trial
Jagiellonian University
Opioid-based Versus Opioid-free Endotracheal Intubation
Aretaieion University Hospital
Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
Clexio Biosciences Ltd.
LSD-Perceptual-Choice-Study
University Hospital, Basel, Switzerland
Psilocybin in Functional Neurological Disorder
King's College London
Psilocybin in Alcohol Use Disorder With Comorbid Depression
Centre Hospitalier Universitaire de Nīmes
Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Molecular Imaging Study of Harmine/DMT: a Basic Research Approach
Insel Gruppe AG, University Hospital Bern
Ketamine for MS Fatigue
Alta Bates Summit Medical Center
Sustained Ketamine Effectiveness for Suicidal Ideation
University Hospital, Montpellier
Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose
University Hospital, Basel, Switzerland
Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia
Endeavor Health
Consciousness, Psilocybin, and Well-Being
University of Wisconsin, Madison
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
University of Chicago
COnventional Vs. Optimised PERiprocedural Analgosedation Vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)
Charles University, Czech Republic
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans
University of Zurich
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
University Hospital, Antwerp
Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial
Unity Health Toronto
Tapping in Together: A Pilot Study on Group Acupuncture for Ketamine Experience Integration
Academy of Oriental Medicine Austin
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
Dr. Leslie Morland
KET-RO Plus RO DBT for Treatment Resistant Depression
Washington University School of Medicine
Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery
Hospital dos Lusíadas
Group MDMA-therapy for Veterans With PTSD
Portland VA Research Foundation, Inc
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
Kevin Boehnke
Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1)
Grace Lim, MD, MS
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Anders Fink-Jensen, MD, DMSci
Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects
University Hospital, Basel, Switzerland
Anesthesia Depth During Opioid Free Anesthesia
Region Halland
Prosocial Effects of MDMA
University of Chicago
Microdosing Psychedelics to Improve Mood
Rotem Petranker
A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Bristol-Myers Squibb
Brain Network Dynamics of Depression During Esketamine Treatment
University of North Carolina, Chapel Hill
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Centre for Addiction and Mental Health
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
University of Washington
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.